TQVIX
Price
$23.13
Change
+$0.23 (+1.00%)
Updated
Sep 11 closing price
Net Assets
95.85M
VVIAX
Price
$87.39
Change
+$0.67 (+0.77%)
Updated
Sep 11 closing price
Net Assets
262.3B
Interact to see
Advertisement

TQVIX vs VVIAX

TQVIX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
TQVIX vs. VVIAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TQVIX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 262B vs. TQVIX (95.8M). VVIAX pays higher dividends than TQVIX: VVIAX (1.81) vs TQVIX (1.27). TQVIX was incepted earlier than VVIAX: TQVIX (11 years) vs VVIAX (26 years). TQVIX (1.07) is less costly to investors than VVIAX (0.05). TQVIX is a more actively managed with annual turnover of: 87.60 vs. VVIAX (8.00). VVIAX has a lower initial minimum investment than TQVIX: VVIAX (3000) vs TQVIX (500000). TQVIX annual gain was more profitable for investors over the last year : 21.55 vs. VVIAX (19.53). VVIAX return over 5 years is better than : 60.72 vs. TQVIX (53.68).
TQVIXVVIAXTQVIX / VVIAX
Total Expense Ratio0.530.051,060%
Annual Report Gross Expense Ratio1.070.052,140%
Fund Existence11 years26 years-
Gain YTD21.03616.387128%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets95.8M262B0%
Annual Yield % from dividends1.271.8170%
Returns for 1 year21.5519.53110%
Returns for 3 years48.3755.7287%
Returns for 5 years53.6860.7288%
Returns for 10 years139.87160.5987%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDFAX92.06N/A
N/A
Fidelity Select Consumer Staples Port
GSGCX51.28N/A
N/A
Goldman Sachs Equity Income C
TISEX23.40N/A
N/A
Nuveen Quant Small Cap Equity R6
BSPSX883.20N/A
N/A
iShares S&P 500 Index Service
VVJEX12.16N/A
N/A
Voya VACS Series MCV Fund